Placebo response in two long-term randomized psoriasis studies that were negative for rosiglitazone.

Ellis, Charles N; Barker, Jonathan N; Haig, Ann E; Parker, Christine A; Daly, Susan; Jayawardene, Deepthi A

Ellis, Charles N; Barker, Jonathan N; Haig, Ann E; Parker, Christine A; Daly, Susan; Jayawardene, Deepthi A.

Affiliation

Ellis CN; Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Am J Clin Dermatol ; 8(2): 93-102, 2007.

Article in En | MEDLINE | ID: mdl-17428114

Subject(s)

Dermatologic Agents/therapeutic use; Placebo Effect; Psoriasis/drug therapy; Thiazolidinediones/therapeutic use; Adolescent; Adult; Aged; C-Reactive Protein/analysis; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Rosiglitazone; Severity of Illness Index

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Placebo Effect / Thiazolidinediones / Dermatologic Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Clin Dermatol Journal subject: DERMATOLOGIA Year: 2007 Document type: Article Affiliation country: United States Country of publication: New Zealand

Search on Google

Add to My VHL

XML

PubMed Links